Acessibilidade / Reportar erro

Susceptibility in vitro of isolates of Stenotrophomonas maltophilia: comparison of three methodologies (disc diffusion, e-test and agar-dilution)

SUMMARY OF THESIS* * This thesis is available at the Library of the Instituto de Medicina Tropical de São Paulo

Susceptibility in vitro of isolates of Stenotrophomonas maltophilia: comparison of three methodologies (disc diffusion, e-test and agar-dilution)

Antonio Carlos Nicodemo

Departamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina da USP, acnicode@usp.br

NICODEMO, Antonio Carlos - Sensibilidade in vitro de isolados de Stenotrophomonas maltophilia: comparação de três metodologias (disco-difusão, E-test e ágar-diluição). São Paulo, 2003. (Tese Livre Docência - Faculdade de Medicina da Universidade de São Paulo).

Stenotrophomonas has emerged throughout the last years as an important agent of nosocomial infection. The treatment of S. maltophilia is difficult due to the intrinsic and/or acquired resistance to many classes of antibiotics, such as beta-lactams, aminoglycosides and carbapenems. Currently, there still are doubts concerning the accuracy and inter-relation among the several methods of evaluation of the in vitro susceptibility and which antimicrobial agents are more adequate for the treatment.

OBJECTIVE: The present study was performed with the objective of evaluating and comparing the methods of disc diffusion, E-test and agar-dilution for the determination of the sensibility profile of S. maltophilia to seven antibiotics and also to verify the activity of these drugs against the strains studied.

MATERIAL AND METHODS: A total of 70 clinical isolates of S. maltophilia strains were consecutively collected from May 2000 to May 2002 from individual patients of "Hospital Sírio-Libanês". The antimicrobial susceptibility tests were carried out and interpreted according to the National Committee for Clinical Laboratory Standards (NCCLS) recommendations. The E-test was carried out according to the manufacturer's instructions.

RESULTS AND CONCLUSIONS: There was good agreement among the distinct susceptibility testing results for chloramphenicol, doxycycline, gatifloxacin, trimethoprim-sulfamethoxazole and ticarcillin clavulanate, suggesting that the disc diffusion and E-test methods are reliable for testing this group of antimicrobials against S. maltophilia. In contrast, a weak correlation was found between the disc diffusion and agar dilution techniques for testing polymyxin B and colistin with unacceptable very major error rates (18.1% and 22.7% for polymyxin B and colistin, respectively). Trimethoprim-sulfamethoxazole (MIC50, 0.06 mg/L; 98.5% susceptible) and gatifloxacin (MIC50, 0.12 mg/L; 98.5% susceptible) were the most potent antimicrobial agents tested against S. maltophilia isolates. In contrast, the worst in vitro activity was found for ticarcillin-clavulanate (MIC50, 16 mg/L; 59.1% susceptible). Although our results confirm that trimethoprim-sulfamethoxazole, gatifloxacin and doxycycline have an excellent in vitro activity against S. maltophilia, further clinical studies are necessary to evaluate the clinical efficacy of these compounds for the treatment of S. maltophilia infections, since no randomized controlled trials have been carried out and no correlation between the clinical response and susceptibility testing results has been reported.

The comparison of the disagreeing results between the disc diffusion and agar dilution methods demonstrated a great quantity of "false-susceptibles" obtained by disc diffusion and reaffirm the low accuracy of this method to test the polymyxin B and colistin against isolates of S. maltophilia. Therefore, the susceptibility of S. maltophilia to the polymyxins should be evaluated only through dilutional methods.

  • *
    This thesis is available at the Library of the Instituto de Medicina Tropical de São Paulo
  • Publication Dates

    • Publication in this collection
      03 Sept 2004
    • Date of issue
      Aug 2004
    Instituto de Medicina Tropical de São Paulo Av. Dr. Enéas de Carvalho Aguiar, 470, 05403-000 - São Paulo - SP - Brazil, Tel. +55 11 3061-7005 - São Paulo - SP - Brazil
    E-mail: revimtsp@usp.br